Last updated at 19 Aug 2024 10:03 PM
Director
DIN: 01306231
Chetan Mansukhlal Doshi is currently associated with 2 companies as Director. They serve as a Director at U.D. INDUSTRIES PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 01306231.Chetan Mansukhlal Doshi has previously been associated with 1 company in roles such as Director appointed in casual vacancy.Chetan Mansukhlal Doshi is currently involved in 1 different role. Their most recent position is with OM PHARMACEUTICALS LIMITED as a Director. The first company Chetan Mansukhlal Doshi was appointed to as a director was U.D. INDUSTRIES PRIVATE LIMITED. Chetan Mansukhlal Doshi is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Chetan Mansukhlal Doshi is currently associated with 2 companies as Director. They serve as a Director at U.D. INDUSTRIES PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 01306231.Chetan Mansukhlal Doshi has previously been associated with 1 company in roles such as Director appointed in casual vacancy.Chetan Mansukhlal Doshi is currently involved in 1 different role. Their most recent position is with OM PHARMACEUTICALS LIMITED as a Director. The first company Chetan Mansukhlal Doshi was appointed to as a director was U.D. INDUSTRIES PRIVATE LIMITED. Chetan Mansukhlal Doshi is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (1)
3y 9m 1y 11m Interval
Company Name | Designation | Date of Appointment |
---|---|---|
U.D. INDUSTRIES PRIVATE LIMITED | Director | 02-Apr-2007 |
OM PHARMACEUTICALS LIMITED | Director | 30-Sep-2022 |